Clinical Trials Insight: 700022700
Phase of Trial: Phase I
Latest Information Update: 09 Feb 2010
At a glance
- Drugs Laninamivir (Primary)
- Indications Influenza A virus H1N1 subtype; Influenza A virus H5N1 subtype; Influenza A virus H9N2 subtype; Influenza B virus infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Daiichi Sankyo Company
- 09 Feb 2010 Results published in the Journal of Clinical Pharmacology.
- 24 Apr 2007 New trial record.